Treatment with metoprolol succinate, aselective beta adrenergic blocker, lowersblood pressure without altering insulinsensitivity in diabetic patients

Journal of Clinical Hypertension

Volumn 10, Issue 1, 2008, Pages 51-57

  Falkner, Bonita ^a   Kushner, Harvey ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b BioMedical Computer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; INSULIN; METOPROLOL; METOPROLOL SUCCINATE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; DIABETIC ANGIOPATHY; DRUG EFFECT; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; METOPROLOL; MIDDLE AGED;

EID: 40049099767     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2007.07458.x     Document Type: Article

References (26)

1. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434-444.
2. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
3. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
4. Black HR, Sica DA. A modern perspective on b-blocker use in hypertension: clinical trials and their influence on clinical practice. J Clin Hypertens (Greenwich). 2007;9(4 suppl 3):10-18.
5. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
6. Jacob S, Rett K, Henriksen EJ. Antihypertensive therapy and insulin sensitivity: Do we have to redefine the role of b-blocking agents? Am J Hypertens. 1998;11:1258-1265.
7. Grimm RH. Antihypertensive therapy: taking lipids into consideration. Am Heart J. 1991;122:910-918.
8. Gress TW, Nieto JF, Shahar E, et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med. 2000;342:905-912.
9. Bakris GL, Fonseca V, Katholi RE, et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004;292:2227-2236.
10. Falkner B, Francos G, Kushner H. Metoprolol succinate, a selective b-adrenergic blocker, has no effect on insulin sensitivity. J Clin Hypertens (Greenwich). 2006;8:336-343.
11. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for Blood Pressure Measurement in Humans and Experimental Animals. Part 1: Blood Pressure Measurement in Humans. A Statement for Professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142-161.
12. Wormsley J, Durnin J. A comparison of the skinfold method with extent of overweight and various heightweight relationships in the assessment of obesity. Br J Nutr. 1999;34:818-823.
13. Heymsfield SB, McManus C, Stevens V, et al. Muscle mass: reliable indicator of protein-energy malnutrition severity and outcome. Am J Clin Nutr. 1982;35:(5 suppl)1192-1199.
14. Rizza RA, Mandarino LJ, Geric JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol. 1981;240:E630-E639.
15. De Fronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
16. Cheng C, Campbell KL, Kushner H, et al. Correlation of oral glucose tolerance test-derived estimates of insulin sensitivity with insulin clamp measurements in an African- American cohort. Metabolism. 2004;53:1107-1112.
17. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and b-cell function from fasting plasma glucose and insulin correlations in man. Diabetologia. 1985;28:412-419.
18. Katz A, Nambi SS, Mather K, et al. Quantitative Insulin Sensitivity Check Index: asimple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-2410.
19. Jacob S, Rett K, Wicklmayr M, et al. Differential effect of chronic treatment with two betablocking agents on insulin sensitivity: the carvedilol-metoprolol study. J Hypertens. 1996;14:489-494.
20. Falkner B, Canessa M, Anzalone D. Effect of angiotensin converting enzyme inhibitor (Lisinopril) on insulin sensitivity and sodium transport in mild hypertension. Am J Hypertens. 1995;8:454-460.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
22. Sica DA. ß-Blockers in hypertension: a reassessment of the benefit of combined α-/ß-blockade. J Clin Hypertens (Greenwich). 2007;9(4 suppl 3):4-9.
23. Grimm RH. Antihypertensive therapy: taking lipids into consideration. Am Heart J. 1991;122:910-918.
24. Lithell H, Pollare T, Vessby B. Metabolic effects of pindolol and propranolol in a double-blind cross-over study n hypertensive patients. Blood Press. 1992;1:92-101.
25. Pollare T, Lithell HO, Selinus I, et al. Sensitivity to insulin during treatment with atenolol and metroprolol: a randomized, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ. 1989;298:1152-1157.
26. Darmansjah I, Wong E, Setiawati A, et al. Pharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: A comparison with conventional formulations of metoprolol and atenolol. J Clin Pharmacol. 1990;30:S39-S45.